Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbubble-based ultrasound contrast enhancement uses gas-filled microbubbles as intravenous contrast agents to improve ultrasound image quality. These microbubbles, typically 1-8 µm in diameter, oscillate and resonate under ultrasound exposure, generating strong backscatter signals. This enhances echogenicity and allows for improved visualization of vasculature, perfusion, and targeted molecular imaging applications. They are composed of a gas core, often perfluorocarbon or sulfur hexafluoride, encased in a biocompatible shell made of phospholipids, proteins, or polymers. The agent remains strictly intravascular due to its size.
Microbubbles enhance ultrasound images through oscillation and resonance in response to ultrasound waves, leading to increased backscatter and harmonic generation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbubble-based Ultrasound Contrast Enhancement.